BaDM

Beneficial owner: the Cypriot company Liorco Investments Ltd, which is owned by Olexandr Dytyatkovskyy and Olexandr Sukhodolskyy.

The businessmen also own a subsidiary company "BaDM-B" (EDRPOU code 39273420). It was registered in 2014 at the same address.

The company's share in the pharmaceutical distribution market exceeds 35%. It works with 18,000 pharmacies and medical institutions.

There are 10 regional structural divisions and 12 representative offices, more than 2800 employees, 300 foreign and 160 domestic partners that manufactur pharmaceutical products.

The company is placed on 60,000 m2 of warehouse space across the country. It offers 12,000 positions of drugs and medical goods.

The company's revenue for 2018 was UAH 31.7bn. According to Focus, Olexandr Dytyakovsky and Olexandr Sukhodolsky are in the bottom of the list of the richest Ukrainians. The journalists estimated the wealth of each of them at $ 50 million.

• In 1994, the company was founded by businessmen from Dnipropetrovsk (now: Dnipro) Olexandr Sukhodolsky, Olexandr Dytyatkovsky, and Volodymyr Bass, the former owner of Dairy House (TM Fanny) and a member of the supervisory board of the Dnipropetrovsk Jewish community. At the same time, they began working with three local pharmaceutical companies.
• In 1996, they signed 20 international contracts for the supply of medicines.
• In 2006, the company became a leader in Ukraine in terms of sales of medicines. It entered into a contract with with 79 leading world manufacturers and suppliers of pharmaceutical products from 24 countries and, in addition, more than 300 contracts with national manufacturers.
• In 2007, the company entered into a contract with 5,000 legal entities and 20,000 pharmacy and medical institutions.
• In 2008, Volodymyr Bass left the register of the company's shareholders.
• According to Prozorro, a public e-procurement system, in May 2020, the company was among the top five suppliers of anti-coronavirus products.

In terms of the number of transactions, BADM ranked fourth in the country (314). The first three places are: Lysoform Medical, a private company (398 tenders during the quarantine period); MTK, a medical center (331); Epicenter K, a network of shopping centers (321).

In December 2019, the Antimonopoly Committee of Ukraine announced that it had fined the company and five other companies totalling UAH 4.5 million for anti-competitive concerted practices. The problem was with prices on drugs made by GSK, a global healthcare company, that were sold through public procurement procedures.

The company has been named Best Distributor of the Year several times.